-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q6ALCRNaor/PSOefHYwn/0VniiPr295v7GymY+PesnO20QgcaUyFNO34ho3C7/k2 kxJCjyFdJY4ikcXWzVxG6w== 0001209721-07-000001.txt : 20070508 0001209721-07-000001.hdr.sgml : 20070508 20070508172621 ACCESSION NUMBER: 0001209721-07-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070507 FILED AS OF DATE: 20070508 DATE AS OF CHANGE: 20070508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 41 MOORES ROAD CITY: FRAZER STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OSBORN JOHN E CENTRAL INDEX KEY: 0001209721 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19119 FILM NUMBER: 07829267 MAIL ADDRESS: STREET 1: 145 BRANDYWINE PKWY CITY: WEST CHESTER STATE: PA ZIP: 19380 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-07 0000873364 CEPHALON INC CEPH 0001209721 OSBORN JOHN E 41 MOORES RD. FRAZER PA 19355 0 1 0 0 Exec VP, General Counsel & Sec Common Stock 2007-05-07 4 M 0 6250 48.20 A 45250 D Common Stock 2007-05-07 4 M 0 5000 48.06 A 50250 D Common Stock 2007-05-07 4 S 0 11250 81.00 D 39000 D Incentive Stock Option 48.20 2007-05-07 4 M 0 2074 0 D 2007-12-17 2013-12-16 Common Stock 2074 2074 D Non-Qualified Stock Option 48.20 2007-05-07 4 M 0 4176 0 D 2007-12-17 2013-12-16 Common Stock 4176 4176 D Non-Qualified Stock Option 48.06 2007-05-07 4 M 0 5000 0 D 2008-12-16 2014-12-15 Common Stock 5000 7920 D Options vest 25% on each annual anniversary of grant and are fully vested 4 years from date of grant. Options expire ten years from date of grant. Carolyn S. Iosca For: John E. Osborn 2007-05-08 -----END PRIVACY-ENHANCED MESSAGE-----